![]() |
|
|
Institute for Preventive Medicine, Nutrition and Cancer, Folkhälsan Research Center and Department of Clinical Chemistry, University of Helsinki, FIN-00014, Helsinki, Finland and * Department of Clinical Nutrition, University of Kuopio, FIN-70211 Kuopio, Finland
3To whom correspondence should be addressed. E-mail: Anna.Linko{at}helsinki.fi.
Whole-grain rye and wheat products are rich in lignans, the precursors of enterolactone (ENL) and alkylresorcinols (ARs), which are phenolic lipids. In this crossover trial, we examined the effect of whole-grain rye bread compared with low-fiber wheat bread on plasma AR levels. Women (n = 39) aged 59 ± 0.94 y (mean ± SEM) were advised to consume rye (214 ± 7.1 g/d) or wheat (178 ± 6.5 g/d) bread (20% of total daily energy intake) in random order for 8 wk. The test periods were separated by an 8-wk washout period. ARs with different homologues and ENL were measured in plasma collected at the beginning (habitual diet) and end of the test bread periods. AR concentrations were higher (P < 0.001) after the rye bread (352 ± 24.7 nmol/L) and habitual diet (97.7 ± 12.1 and 88.3 ± 8.7 nmol/L) periods than after the wheat bread period (36.6 ± 4.2 nmol/L). Plasma AR concentrations were correlated with intake of rye bread (r = 0.34, P = 0.037), and with insoluble fiber from the whole diet during the rye (r = 0.39, P = 0.013) and wheat (r = 0.32, P = 0.047) bread periods. The plasma AR 17:0/21:0 ratio differed after the rye (0.84 ± 0.04) and wheat (0.53 ± 0.08) bread diet periods (P < 0.001). These data strongly suggest that plasma ARs could be used as specific biomarkers for whole-grain rye intake, and their homologue pattern could be used as an indicator of the bread type consumed.
KEY WORDS: alkylresorcinols biomarkers rye bread
This article has been cited by other articles:
![]() |
R. M van Dam and F. B Hu Are alkylresorcinols accurate biomarkers for whole grain intake? Am. J. Clinical Nutrition, April 1, 2008; 87(4): 797 - 798. [Full Text] [PDF] |
||||
![]() |
R. Landberg, A. Kamal-Eldin, A. Andersson, B. Vessby, and P. Aman Alkylresorcinols as biomarkers of whole-grain wheat and rye intake: plasma concentration and intake estimated from dietary records Am. J. Clinical Nutrition, April 1, 2008; 87(4): 832 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Koskela, A.-M. Linko-Parvinen, P. Hiisivuori, A. Samaletdin, A. Kamal-Eldin, M. J. Tikkanen, and H. Adlercreutz Quantification of Alkylresorcinol Metabolites in Urine by HPLC with Coulometric Electrode Array Detection Clin. Chem., July 1, 2007; 53(7): 1380 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Linko-Parvinen, R. Landberg, M. J. Tikkanen, H. Adlercreutz, and J. L. Penalvo Alkylresorcinols from Whole-Grain Wheat and Rye Are Transported in Human Plasma Lipoproteins J. Nutr., May 1, 2007; 137(5): 1137 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Landberg, A.-M. Linko, A. Kamal-Eldin, B. Vessby, H. Adlercreutz, and P. Aman Human Plasma Kinetics and Relative Bioavailability of Alkylresorcinols after Intake of Rye Bran J. Nutr., November 1, 2006; 136(11): 2760 - 2765. [Abstract] [Full Text] [PDF] |
||||